Immunization, Hib3 (% of children ages 12-23 months) in Tuvalu
Tuvalu: Immunization, Hib3 (% of children ages 12-23 months) was 94.0% in 2024. ▬ Flat
Immunization, Hib3 in Tuvalu, 2009–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
The most recent figure for immunization, hib3 in Tuvalu is 94.0%, measured in 2024.
That represents a change of up 5.6% over ten years.
Over the whole period, immunization, hib3 in Tuvalu peaked at 97.0% in 2012 and was at its lowest, 84.0%, in 2009.
That places Tuvalu 64th out of 191 countries with data for 2024, putting it in the middle of the range.
Immunization, Hib3 (% of children ages 12-23 months) in Tuvalu, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 2009 | 84.0% | — |
| 2010 | 89.0% | +6.0% |
| 2011 | 96.0% | +7.9% |
| 2012 | 97.0% | +1.0% |
| 2013 | 90.0% | -7.2% |
| 2014 | 89.0% | -1.1% |
| 2015 | 96.0% | +7.9% |
| 2016 | 94.0% | -2.1% |
| 2017 | 96.0% | +2.1% |
| 2018 | 89.0% | -7.3% |
| 2019 | 92.0% | +3.4% |
| 2020 | 93.0% | +1.1% |
| 2021 | 94.0% | +1.1% |
| 2022 | 91.0% | -3.2% |
| 2023 | 94.0% | +3.3% |
| 2024 | 94.0% | +0.0% |
Tuvalu compared with similar countries
- Tuvalu's 94.0% is above the median for upper middle income countries, which is 91.0%, 1.0× the median. (57 countries reporting)
- Tuvalu's 94.0% is above the median for East Asia & Pacific, which is 93.0%, 1.0× the median. (29 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 84.0% | 84.0% | 84.0% | 1 |
| 2010s | 92.8% | 89.0% | 97.0% | 10 |
| 2020s | 93.2% | 91.0% | 94.0% | 5 |
Countries ranked near Tuvalu
- 64 Armenia 94.0% compare
- 64 Barbados 94.0% compare
- 64 Botswana 94.0% compare
- 64 Bulgaria 94.0% compare
- 64 Cyprus 94.0% compare
- 64 Fiji 94.0% compare
- 64 Iceland 94.0% compare
- 64 India 94.0% compare
- 64 Kiribati 94.0% compare
- 64 Poland 94.0% compare
- 64 Seychelles 94.0% compare
- 64 Spain 94.0% compare
- 64 Uruguay 94.0% compare
More health data for Tuvalu
- Un projection of annual infant deaths, annual growth rate -100 % change on previous year (2095)
- Heat deaths vs projected death rates, annual growth rate 1.12 % change on previous year (2090)
- Un projection of annual infant deaths 0 (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2019)
- Population ages 00-04, female, annual growth rate -3.2 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.051 units per person (2025)
- Population ages 00-04, male, annual growth rate -4.28 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, male, per capita 0.0566 units per person (2025)
Frequently asked questions
- What is immunization, hib3 in Tuvalu?
- Immunization, hib3 in Tuvalu was 94.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Tuvalu?
- The highest recorded value was 97.0% in 2012.
- What is the lowest immunization, hib3 recorded in Tuvalu?
- The lowest recorded value was 84.0% in 2009.
- How does Tuvalu rank for immunization, hib3?
- Tuvalu ranks 64th out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Tuvalu?
- Over the last ten years it is up 5.6%. The long-run trend across the full record is flat.
- Where does this Tuvalu data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 16 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.